Quarterly report pursuant to Section 13 or 15(d)

DEBT - Narrative (Details)

v3.22.2.2
DEBT - Narrative (Details)
1 Months Ended 9 Months Ended
Sep. 10, 2021
Oct. 31, 2022
USD ($)
Sep. 30, 2022
USD ($)
Jul. 31, 2022
USD ($)
Apr. 30, 2022
USD ($)
Mar. 31, 2022
USD ($)
note
month
Feb. 28, 2022
USD ($)
Sep. 30, 2022
USD ($)
Sep. 30, 2021
USD ($)
Debt Instrument [Line Items]                  
Finance lease, liability     $ 110,824,000       $ 3,265,000 $ 110,824,000  
Incremental borrowing rate             11.60%    
Proceeds from long-term lines of credit               24,207,000 $ 0
NuLeaf                  
Debt Instrument [Line Items]                  
Debt instrument term       5 years 5 years        
Payment for contingent consideration liability       $ 3,000,000          
Nature's Remedy                  
Debt Instrument [Line Items]                  
Payment for contingent consideration liability       $ 5,000,000          
Apothecarium Notes Due March 16, 2027                  
Debt Instrument [Line Items]                  
Number of debt instruments | note           2      
Apothecarium Notes Due March 16, 2027 | Acquisition-related promissory notes payable                  
Debt Instrument [Line Items]                  
Debt instrument principal amount           $ 9,853,000      
Periodic payment, principal           $ 3,448,000      
Periodic payment, period           21 months      
Remaining balance monthly installments, term | month           39      
Nuleaf Unsecured Promissory Notes | Acquisition-related promissory notes payable | NuLeaf                  
Debt Instrument [Line Items]                  
Debt instrument interest rate         8.00%        
Debt instrument principal amount         $ 15,750,000        
NuLeaf Five-Year Note | NuLeaf                  
Debt Instrument [Line Items]                  
Debt instrument term       5 years          
Nature's Remedy Three-Year Note | Nature's Remedy                  
Debt Instrument [Line Items]                  
Debt instrument term 3 years   3 years            
Acquisition Facility | Acquisition Facility | Revolving Credit Facility                  
Debt Instrument [Line Items]                  
Proceeds from long-term lines of credit         $ 25,000,000        
Credit Facility Maturing July 18, 2027 | Acquisition Facility | Revolving Credit Facility                  
Debt Instrument [Line Items]                  
Line of credit facility, maximum borrowing capacity       $ 2,800,000          
Proceeds from long-term lines of credit               $ 1,050,000  
Debt instrument interest rate     7.50%         7.50%  
Credit Facility Maturing July 18, 2027 | Acquisition Facility | Revolving Credit Facility | Prime Rate                  
Debt Instrument [Line Items]                  
Debt instrument basis spread on variable rate               2.00%  
Credit Facility Maturing July 18, 2027 | Acquisition Facility | Revolving Credit Facility | Subsequent Event                  
Debt Instrument [Line Items]                  
Proceeds from long-term lines of credit   $ 1,750,000